摘要
目的:比较依达拉奉治疗(Edaravone)脑血栓形成与脑栓塞的疗效差别。方法:对我院2 0 0 4年1月～2 0 0 4年10月收治的脑血栓形成和脑栓塞患者2 2例给予依达拉奉治疗。结果:治疗后患者的主要神经症状、日常生活能力均有改善,脑栓塞的神经功能缺损评分(ESS)和日常生活活动量表(ADL)评分较脑血栓形成高。结论:依达拉奉在治疗脑梗塞急性期中发挥着重要的作用,且脑栓塞的疗效优于脑血栓形成。
Objective:To investigate the efficacy of Edaravone in the treatment of patients with acute cerebral and atherothrombotic brain infarction.Method:From Jan.2004 to Oct.2004,20 patients with acute cerebral and atherothrombotic brain infarction were taken treatment with edaravone.Results:The Barthel exponent (ADL) and the European Stroke Scale (ESS) assessed functional outcome showed differences in favor of edaravone. Conclusions:Edaravone is important in the treatment of ischemic stroke, especially acute cerebral.
出处
《现代预防医学》
CAS
北大核心
2005年第6期686-687,共2页
Modern Preventive Medicine
关键词
脑血栓形成
脑栓塞
依达拉奉
自由基
Atherothrombotic brain infarction
Acute cerebral
Edaravone
Free radical
